- It’s the Drug Industry’s Turn to Tremble Before Trump Bloomberg News by Robert Langreth, Caroline Chen and Jared Hopkins—In a hallway of a San Francisco luxury hotel, investors huddled around a computer screen watching dozens of drug stocks plummet as President-elect Donald Trump lit into pharma companies, declaring that “they’re getting away with murder.” As for Obamacare, he said, “it’ll be repeal and replace.” The mood was shock and disbelief as thousands of health care investors, bankers, and executives gathered at the cramped Westin St. Francis Hotel. Many had paid thousands of dollars to attend the industry’s biggest investing get-together of the year, the four-day J.P. Morgan Healthcare Conference. And they had spent the last days speculating about what policies Trump would push in health care. Then the bomb dropped.